47.3

47.30 (-0.72%)

As of Mar 01, 2024

ARVINAS, INC. [ARVN]

Source: 

Company Overview

Arvinas, Inc. is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins. We use our PROTAC Discovery Engine, our proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

CountryUS
Headquartersnew havenconnecticut
Phone Number(203) 535-1456
Industrypharmaceutical preparations
CEOJohn Houston
Websitewww.arvinas.com